EBR Systems announced that it received commitments for a fully underwritten institutional placement to raise $36.1 million ...

This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...

According to the study’s abstract in The Lancet, TAVR with Acurate neo2 failed to meet non-inferiority. It also resulted in ...

Cardiawave shared positive 12-month results from a study evaluating its Valvosoft non-invasive ultrasound therapy (NIUT) ...

Elixir Medical announced three-year results from a large randomized controlled trial of its DynamX coronary bioadaptor system ...

Medtronic (NYSE: MDT) announced some personnel moves, including the departure of a longtime leader across multiple business ...

TriCares today shared results from a first-in-human trial supporting its Topaz transcatheter tricuspid valve replacement ...

Endiatx co-founder and former CEO Torrey Smith tells MassDevice he's "doing advanced PillBot R&D" and called his replacement "awesome." ...